{"id":"https://openalex.org/W1669615352","doi":null,"title":"Cerebrospinal Fluid Biomarkers For Parkinson's Disease and L-DOPA-induced Dyskinesia","display_name":"Cerebrospinal Fluid Biomarkers For Parkinson's Disease and L-DOPA-induced Dyskinesia","publication_year":2015,"publication_date":"2015-01-01","ids":{"openalex":"https://openalex.org/W1669615352","mag":"1669615352"},"language":"en","primary_location":{"id":"pmh:oai:sdu.dk:openaire/da6b540d-2e2b-45b4-88b7-e0eea64eeefd","doi":null,"is_oa":true,"landing_page_url":"https://portal.findresearcher.sdu.dk/da/publications/da6b540d-2e2b-45b4-88b7-e0eea64eeefd","pdf_url":null,"source":{"id":"https://openalex.org/S4306400423","display_name":"University of Southern Denmark Research Portal (University of Southern Denmark)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177969490","host_organization_name":"University of Southern Denmark","host_organization_lineage":["https://openalex.org/I177969490"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Dammann Andersen, A 2017, 'Cerebrospinal Fluid Biomarkers For Parkinson's Disease and L-DOPA-induced Dyskinesia'.","raw_type":"other"},"volume":null,"type":"other","is_traditional":false,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://portal.findresearcher.sdu.dk/da/publications/da6b540d-2e2b-45b4-88b7-e0eea64eeefd","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101537039","display_name":"Andreas Dammann Andersen","orcid":"https://orcid.org/0000-0002-9625-1474","observed_orcids":["https://orcid.org/0000-0002-9625-1474"]},"institutions":[{"id":"https://openalex.org/I177969490","display_name":"University of Southern Denmark","ror":"https://ror.org/03yrrjy16","country_code":"DK","type":"education","lineage":["https://openalex.org/I177969490"]},{"id":"https://openalex.org/I4210148601","display_name":"Sygehus S\u00f8nderjylland","ror":"https://ror.org/04q65x027","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I4210148601"]}],"countries":["DK"],"is_corresponding":true,"raw_author_name":"Andreas Dammann Andersen","raw_affiliation_strings":["Kredsl\u00f8bscenter","SDU, The Faculty of Health Sciences, Department of Regional Health Research, IRS - Hospital S\u00f8nderjylland, DK"],"raw_orcid":"https://orcid.org/0000-0002-9625-1474","affiliations":[{"raw_affiliation_string":"Kredsl\u00f8bscenter","institution_ids":[]},{"raw_affiliation_string":"SDU, The Faculty of Health Sciences, Department of Regional Health Research, IRS - Hospital S\u00f8nderjylland, DK","institution_ids":["https://openalex.org/I177969490","https://openalex.org/I4210148601"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5101537039"],"corresponding_institution_ids":["https://openalex.org/I177969490","https://openalex.org/I4210148601"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10919","display_name":"Deep Brain Stimulation and Movement Disorders","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13991","display_name":"Nuclear Receptors and Signaling","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":1.0},{"id":"https://openalex.org/keywords/levodopa-induced-dyskinesia","display_name":"levodopa-induced dyskinesia","score":0.9959999918937683},{"id":"https://openalex.org/keywords/cerebrospinal-fluid-biomarkers","display_name":"cerebrospinal fluid biomarkers","score":1.0},{"id":"https://openalex.org/keywords/alpha-synuclein","display_name":"alpha-synuclein","score":0.9909999966621399},{"id":"https://openalex.org/keywords/lysosomal-enzymes","display_name":"lysosomal enzymes","score":0.9580000042915344},{"id":"https://openalex.org/keywords/extracellular-signal-regulated-kinase","display_name":"extracellular signal-regulated kinase","score":0.8220000267028809},{"id":"https://openalex.org/keywords/erk-signaling","display_name":"ERK signaling","score":0.925000011920929},{"id":"https://openalex.org/keywords/dopamine-replacement-therapy","display_name":"dopamine replacement therapy","score":0.8130000233650208},{"id":"https://openalex.org/keywords/neurodegeneration","display_name":"neurodegeneration","score":0.6660000085830688},{"id":"https://openalex.org/keywords/rat-model","display_name":"rat model","score":0.5109999775886536},{"id":"https://openalex.org/keywords/metabolomics","display_name":"metabolomics","score":0.8870000243186951},{"id":"https://openalex.org/keywords/early-diagnosis","display_name":"early diagnosis","score":0.5889999866485596},{"id":"https://openalex.org/keywords/prognosis","display_name":"prognosis","score":0.5849999785423279},{"id":"https://openalex.org/keywords/unified-parkinson-s-disease-rating-scale","display_name":"Unified Parkinson's Disease Rating Scale","score":0.8320000171661377}],"concepts":[{"id":"https://openalex.org/C2779651940","wikidata":"https://www.wikidata.org/wiki/Q54196","display_name":"Cerebrospinal fluid","level":2,"score":0.8539106845855713},{"id":"https://openalex.org/C2780405171","wikidata":"https://www.wikidata.org/wiki/Q629444","display_name":"Dyskinesia","level":4,"score":0.7170035243034363},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.6289107799530029},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5486132502555847},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4977152645587921},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38170695304870605},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.33017730712890625},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.19626614451408386}],"mesh":[],"locations_count":4,"locations":[{"id":"pmh:oai:sdu.dk:openaire/da6b540d-2e2b-45b4-88b7-e0eea64eeefd","doi":null,"is_oa":true,"landing_page_url":"https://portal.findresearcher.sdu.dk/da/publications/da6b540d-2e2b-45b4-88b7-e0eea64eeefd","pdf_url":null,"source":{"id":"https://openalex.org/S4306400423","display_name":"University of Southern Denmark Research Portal (University of Southern Denmark)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177969490","host_organization_name":"University of Southern Denmark","host_organization_lineage":["https://openalex.org/I177969490"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Dammann Andersen, A 2017, 'Cerebrospinal Fluid Biomarkers For Parkinson's Disease and L-DOPA-induced Dyskinesia'.","raw_type":"other"},{"id":"pmh:oai:sdu.dk:openaire_cris_publications/5bc1d8c4-e39d-48ec-a38c-71180965ca36","doi":null,"is_oa":false,"landing_page_url":"https://portal.findresearcher.sdu.dk/da/publications/5bc1d8c4-e39d-48ec-a38c-71180965ca36","pdf_url":null,"source":{"id":"https://openalex.org/S4306400423","display_name":"University of Southern Denmark Research Portal (University of Southern Denmark)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177969490","host_organization_name":"University of Southern Denmark","host_organization_lineage":["https://openalex.org/I177969490"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Dammann Andersen, A 2015, 'Cerebrospinal fluid biomarkers for Parkinson's disease and L-DOPA-induced dyskinesia', International Student Research Forum 2015, Aberdeen, Scotland, Aberdeen, Storbritannien, 19/07/2015 - 23/07/2015.","raw_type":"info:eu-repo/semantics/conferenceObject"},{"id":"mag:1669615352","doi":null,"is_oa":false,"landing_page_url":"http://findresearcher.sdu.dk/portal/da/publications/cerebrospinal-fluid-biomarkers-for-parkinsons-disease-and-ldopainduced-dyskinesia(5bc1d8c4-e39d-48ec-a38c-71180965ca36).html","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},{"id":"mag:2792143282","doi":null,"is_oa":false,"landing_page_url":"https://portal.findresearcher.sdu.dk/da/publications/biomark%C3%B8rer-i-spinalv%C3%A6sken-for-parkinsons-sygdom-og-l-dopa-induce","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:oai:sdu.dk:openaire/da6b540d-2e2b-45b4-88b7-e0eea64eeefd","doi":null,"is_oa":true,"landing_page_url":"https://portal.findresearcher.sdu.dk/da/publications/da6b540d-2e2b-45b4-88b7-e0eea64eeefd","pdf_url":null,"source":{"id":"https://openalex.org/S4306400423","display_name":"University of Southern Denmark Research Portal (University of Southern Denmark)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177969490","host_organization_name":"University of Southern Denmark","host_organization_lineage":["https://openalex.org/I177969490"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Dammann Andersen, A 2017, 'Cerebrospinal Fluid Biomarkers For Parkinson's Disease and L-DOPA-induced Dyskinesia'.","raw_type":"other"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2794112138","https://openalex.org/W2255728986","https://openalex.org/W2033132890","https://openalex.org/W2592130454","https://openalex.org/W2126965340","https://openalex.org/W2148575698","https://openalex.org/W7218159031","https://openalex.org/W7099786638","https://openalex.org/W2903636274","https://openalex.org/W2016805206"],"abstract_inverted_index":{"Parkinson\u2019s":[0,238],"disease":[1,22,83],"(PD)":[2],"is":[3,57,149],"a":[4,120],"common":[5],"disease,":[6],"affecting":[7],"1%":[8],"of":[9,16,20,26,37,64,81,89,111,123,126,134,146,154,162,165,201,228,257,275,290,329,348],"the":[10,21,24,32,62,78,82,87,103,124,132,150,158,198,226,236,244,330,349],"population":[11],"older":[12],"than":[13],"60":[14],"years":[15],"age[1].":[17],"Neuropathological":[18],"characteristics":[19],"include":[23],"presence":[25],"alpha-synuclein":[27,190],"containing":[28],"Lewy":[29],"bodies":[30],"in":[31,43,105,157,172,225,309],"brain":[33],"stem":[34],"and":[35,107,128,138,142,152,167,176,191,207,216,243,279,339],"loss":[36],"nigrostriatal":[38],"dopaminergic":[39],"neurons,":[40],"which":[41],"result":[42],"motor":[44],"deficits":[45],"that":[46,101],"are":[47,231],"used":[48],"as":[49,169,171,189],"diagnostic":[50],"criteria":[51],"for":[52,136,186],"PD[2].":[53],"So":[54],"far":[55],"there":[56],"no":[58],"treatment":[59],"available":[60],"slowing":[61],"progression":[63],"PD.":[65],"The":[66,144],"otherwise":[67],"effective":[68],"dopamine":[69],"replacement":[70],"therapy":[71],"not":[72,118],"only":[73,119],"loses":[74],"its":[75],"effectiveness":[76],"during":[77],"natural":[79],"course":[80],"but":[84,130],"also":[85,131,232],"increases":[86],"risk":[88],"developing":[90],"debilitating":[91],"involuntary":[92],"movements":[93],"called":[94],"L-DOPA-induced":[95,291],"dyskinesia":[96],"(LID)[3].":[97],"Developing":[98],"drug":[99,113],"treatments":[100],"slow":[102],"neurodegeneration":[104],"PD":[106,127,166,179,187],"prevents":[108],"adverse":[109],"effects":[110],"current":[112],"treatments,":[114],"including":[115],"LID,":[116,129],"requires":[117],"better":[121],"understanding":[122],"pathophysiology":[125],"development":[133,151],"biomarkers":[135,156,185,220,308],"earlier":[137],"more":[139],"precise":[140],"diagnosis":[141],"prognosis.":[143],"purpose":[145],"this":[147],"study":[148],"evaluation":[153],"proposed":[155],"cerebrospinal":[159],"fluid":[160,307],"(CSF)":[161],"rat":[163,199],"models":[164],"LID":[168,202],"well":[170],"patients":[173],"with":[174,180],"early":[175],"late":[177],"stage":[178],"or":[181],"without":[182],"LID.":[183],"Potential":[184],"such":[188],"lysosomal":[192],"enzymes[4]":[193],"will":[194,211,221],"be":[195,212,223],"analyzed.":[196],"In":[197],"model":[200],"extracellular":[203],"regulated":[204],"kinases":[205],"(ERK1/2)":[206],"other":[208],"signalling":[209],"proteins":[210],"studies":[213],"through":[214],"metabolomics":[215],"quantitative":[217],"immunoassays.":[218],"Promising":[219],"subsequently":[222],"analysed":[224],"CSF":[227],"patients,":[229],"who":[230],"clinically":[233],"rated":[234],"using":[235],"Unified":[237,245,331],"Disease":[239,333],"rating":[240],"scale":[241,337],"(UPDRS)[5]":[242],"Dyskinesia":[246],"Rating":[247,334],"Scale":[248,335],"(UDysRS).":[249],"1.":[250],"de":[251],"Lau":[252],"LM,":[253],"Breteler":[254],"MM.":[255],"Epidemiology":[256],"Parkinson's":[258,276,332],"disease.":[259,311],"Lancet":[260,282],"neurology.":[261,283],"2006;5(6):525-35.":[262],"2.":[263],"Rodriguez-Oroz":[264],"MC,":[265],"Jahanshahi":[266],"M,":[267],"Krack":[268],"P,":[269],"et":[270,304,323],"al.":[271,305,324],"Initial":[272],"clinical":[273],"manifestations":[274],"disease:":[277],"features":[278],"pathophysiological":[280],"mechanisms.":[281],"2009;8(12):1128-39.":[284],"3.":[285],"Jenner":[286],"P.":[287],"Molecular":[288],"mechanisms":[289],"dyskinesia.":[292],"Nature":[293,312],"reviews":[294,313],"Neuroscience.":[295],"2008;9(9):665-77.":[296],"4.":[297],"Parnetti":[298],"L,":[299],"Castrioto":[300],"A,":[301],"Chiasserini":[302],"D,":[303],"Cerebrospinal":[306],"Parkinson":[310],"Neurology.":[314],"2013;9(3):131-40.":[315],"5.":[316],"Goetz":[317],"CG,":[318],"Tilley":[319],"BC,":[320],"Shaftman":[321],"SR,":[322],"Movement":[325,343,350],"Disorder":[326,351],"Society-sponsored":[327],"revision":[328],"(MDS-UPDRS):":[336],"presentation":[338],"clinimetric":[340],"testing":[341],"results.":[342],"disorders":[344],":":[345],"official":[346],"journal":[347],"Society.":[352],"2008;23(15):2129-70.":[353]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}